LivaNova (LIVN)

• Market cap: $2.12B
• 1 day: -0.64%
• 5 days: -2.57%
• 1 month: -6.45%
• 3 months: -16.33%
• 6 months: -25.80%
• Year to date: -16.33%
• 1 year: -29.24%
• 5 years: -2.11%
• 10 years: -44.19%
• Sector: Healthcare
• Industry: Electromedical & Electrotherapeutic Apparatus

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

361% more call options, than puts

Call options by funds: $3.35M | Put options by funds: $727K

57% more repeat investments, than reductions

Existing positions increased: 108 | Existing positions reduced: 69

50% more funds holding in top 10

Funds holding in top 10: 2 [Q3] → 3 (+1) [Q4]

41% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 34

5% more funds holding

Funds holding: 242 [Q3] → 254 (+12) [Q4]

4.14% more ownership

Funds ownership: 96.11% [Q3] → 100.25% (+4.14%) [Q4]

8% less capital invested

Capital invested by funds: $2.74B [Q3] → $2.52B (-$221M) [Q4]

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $55 41% upside
• Avg. target: $59 51% upside
• High target: $64 64% upside

5 analyst ratings

• positive: 4 80%
• neutral: 1 20%
• negative: 0 0%

Needham Mike Matson 40% 1-year accuracy 50 / 124 met price target	64% upside $64	Buy Reiterated	17 Mar 2025
Barclays Matt Miksic 59% 1-year accuracy 24 / 41 met price target	43% upside $56	Equal-Weight Maintained	7 Mar 2025
Goldman Sachs David Roman 30% 1-year accuracy 6 / 20 met price target	41% upside $55	Buy Maintained	3 Mar 2025
Mizuho Anthony Petrone 45% 1-year accuracy 10 / 22 met price target	54% upside $60	Outperform Maintained	26 Feb 2025
Stifel Rick Wise 43% 1-year accuracy 15 / 35 met price target	54% upside $60	Buy Maintained	26 Feb 2025